Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 30;121(12):869-873.
doi: 10.1515/jom-2021-0103.

C-reactive protein levels associated with COVID-19 outcomes in the United States

Jacob Lentner  1 , Taylor Adams  1 , Valene Knutson  1 , Sarah Zeien  1 , Hassan Abbas  2 , Ryan Moosavi  2 , Chris Manuel  2 , Thomas Wallace  3 , Adam Harmon  4 , Richard Waters  5 , Samuel Ledford  6 , Rajakrishnan Vijayakrishnan  7 , Nikhil Jagan  8 , Nezar Falluji  9 , Michael DelCore  10 , Curt Bay  11 , Sunny Jhamnani  12
Affiliations
Free article

C-reactive protein levels associated with COVID-19 outcomes in the United States

Jacob Lentner et al. J Osteopath Med. .
Free article

Abstract

Context: COVID-19 caused a worldwide pandemic, and there are still many uncertainties about the disease. C-reactive protein (CRP) levels could be utilized as a prognosticator for disease severity in COVID-19 patients.

Objectives: This study aims to determine whether CRP levels are correlated with COVID-19 patient outcomes and length of stay (LoS).

Methods: A retrospective cohort study was conducted utilizing data obtained between March and May 2020. Data were collected by abstracting past medical records through electronic medical records at 10 hospitals within CommonSpirit Health. Patients were included if they had a positive COVID-19 test from a nasopharyngeal swab sample, and if they were admitted and then discharged alive or had in-hospital mortality and were ≥18 years. A total of 541 patients had CRP levels measured and were included in this report. Patient outcome and LoS were the endpoints measured.

Results: The 541 patients had their CRP levels measured, as well as the demographic and clinical data required for analysis. While controlling for body mass index (BMI), number of comorbidities, and age, the first CRP was significantly predictive of mortality (p<0.001). The odds ratio for first CRP indicates that for each one-unit increase in CRP, the odds of death increased by 0.007. For LoS, the first CRP was a significant predictor (p<0.001), along with age (p=0.002). The number of comorbidities also predicted LoS (p=0.007), but BMI did not. The coefficient for the first CRP indicates that, for each one-unit increase in CRP, LoS increased 0.003 days.

Conclusions: The results indicate that there is a positive correlation between the CRP levels of COVID-19 patients and their respective outcomes with regard to death and LoS.

Keywords: C-reactive protein; COVID-19; mortality; outcomes.

PubMed Disclaimer

References

    1. Zacho, J, Tybjaerg-Hansen, A, Jensen, JS, Grande, P, Sillesen, H, Nordestgaard, BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897–908. https://doi.org/10.1056/NEJMoa0707402.PMID:18971492.
    1. Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. https://doi.org/10.1056/NEJMoa2002032.
    1. Chen, W, Zheng, KI, Liu, S, Yan, Z, Xu, C, Qiao, Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob 2020;19:18. https://doi.org/10.1186/s12941-020-00362-2.
    1. Tan, C, Huang, Y, Shi, F, Tan, K, Ma, Q, Chen, Y, et al.. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol 2020;92:856–62. https://doi.org/10.1002/jmv.25871.
    1. Stringer, D, Braude, P, Myint, PK, Evans, L, Collins, JT, Verduri, A, et al.. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol 2021;50:420–9. https://doi.org/10.1093/ije/dyab012.

Substances

LinkOut - more resources